BPA - HPLC/UHPLC and GC-MS Systems

Forecast overview

Subagency

FDA

NAICS

334516

Program office

HFP ACQUISITION

BPA - HPLC/UHPLC and GC-MS Systems Base + 4 OY The acquisition of new HPL>C/UHPLC and GC-MS systems will provide several benefits to OLOAS operations. First these advanced instruments will increase sample throughput by enabling faster analysis times and the capability to process multiple samples simultaneously. Second, the new system will enhance OLOAS laboratory's efficiency and speed in conducting complex chemical analyses, including multi-residue screening and targeted quantitative methods. Third, the improved instrumentation will lead to an overall enhanced sample flow process for regulatory samples, reducing turnaround times and enabli8ng more rapid regulatory decision-making. Additionally, modern HPLC/UHPLC and GC-MS systems offer improved sensitivity, selectivity, and reliability, which will strengthen the quality and defensibility of analytical results supporting FDA's regulatory actions.

Source

Source

HHS SBCX Forecast Export

Source file

Forecast.csv

Official source

Agency forecast source

Last verified

2026-08-31

Agency-published contact: · TBD@fda.hhs.gov

Forecast research and capture tools

Compare this forecast with broader federal opportunity volume and mix.

• 2026 Federal Opportunity Benchmark
• Federal Opportunity Research hub
• Best capture management software guide
• Free opportunity alerts for upcoming notices